The pregnancy-specific I3 -glycoprotein or schwangerschaftsproteln (SP1) exists in two fo?ms: SPlR is of trophoblastic origin and a glycoprotein with a molecular weight of 90,000 daltons. Together with a second protein which is not produced by the placenta it occurs in its second form SP1 . It is accepted that the rising concentration of SP1 during pregnancy reflects the growth of the placenta. -Is there a detectable release oE SP1 also into the fetal circulation? To study thls question, 9 human term placentae were investigated for 9 0 to 120 min by an in vitro perfused open placental lobule preparation. A radioimmunoassay measured S~l 5 and SPln simultaneously. The sensitivity of determinatlon was < 2,5 ng/ml. Results: 1. In the serum free fetal venous outflow, the concentrations of SP1 in all placentae were between 2,2 -11,75 ng/ml.-The calculated release was 3,43 ng/min/g placenta (median; range 2,38 -4,67). 
PLAs1.a (cAH) BY FLUORESCENCE ENZYME IMMuNoAssAY ( E m )
A"" METHODS. K.Shimozawa, J.Yata, T.Kitaqawa: M.Murata: We have carried out a pllot neonatal mass-screening for CAH d~, e to 21-hydroxylase deficiency(21-OHD) slnce Jan. 1984 in Tokyo, Japan, using two fluorescence EIA methods for "Dlsc-17-hydroxyprogesterone(l7-OHP)" measurement, whlch are a dlrect EIA by B-galzctosldase(I3-gal method) and an extractive EIA by peroxldase(P0D method). Durlng a perlod of 11-months, 25,546 neonates were examlned and the mean+SD values by B-gal and POD methods were 18.11 12.4 and 1.7811.58 ng/ml, respectively. We decided the 99th-per-, centlle value in 13-sal method and the 99th-percentile value andjor 5ng/ml ln POD method as re-sampllng polnts, resulting 0.8%(213/ 25,546) were candldates for re-sampling. If neonates mlght show hlgh "Disc-17-OHPv concentration beyond 20ng/ml, we recalled them ~mrnedlately for detalled evaluations. As a result, 4 lnfants proved to have 21-OHD and the incidence of 21-OHD was calculate~l to be 1/6,387. Although there were many low-blrth weight infants (47.3%) in the candldates for re-sampling, their absolute "Disc-17-OHP" values were much lower than those in the detected patlents.
The present study demonstrates that the fluorescence EIA methods for "Disc-17-OHP" measurement are well applicable for neonatal mass-screening tor CAH and indicates that the lncrdence of 21-OMD 1s much greater than that previously reported by case-assessment.. '' e rest use a bld gchedufe. None give hydrocortlsone or cortrsone once daily. Many distribute drug evenly over cortisol level w a s determined from filter Paper. 0 the day (52%), while others prefer a larger pm dose (30%) or a filter paper disc w a s extracted w i t h dichloromethane lar r am do (189). The maln ind'cati ns or using Florinef are and then cortisol w a s assayed using specific antiserum R~~~::8:f$a~tl:~tz~1t-wa~t1ng. medication. TAUS studies comparing dlfferent a proaches to mani~l t e r paper in addition t o 170B2 deternlnation c a n agement with obj&ctive measures of outcome, suc! as growth rates remarkably reduce t h e recall r a t e o f C.A.B. a t risk. and ultimate stature, seem indicated.
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